Actoverco’s Contribution to the 40th Annual Congress of the Iranian Psychiatric Association
The 40th Annual Congress and the 23rd consecutive gathering of the Iranian Psychiatric Association took place from October 7 to 10 at Milad Hospital in Tehran, with active participation by ActoverCo.
Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress
Ati Pharmed Company introduced two of its products, Actogest and Dofamed, during a scientific symposium held at the 25th International Congress on Reproductive Medicine, the 20th Congress on Stem Cell Technology, and the 19th Midwifery Nursing Seminar at Royan Institute.
Nahaleh Naraqi honors Pharmacist Day with a special message!
Nahale Naraghi honors Pharmacist Day with a special message of gratitude, recognizing the essential role pharmacists play in advancing healthcare and supporting patient well-being
Nahaleh Naraqi’s congratulatory message on the occasion of Doctor’s Day
Nahale Naraghi honors National Doctors Day in Iran, coinciding with Avicenna’s birthday.
Treatment and Reduction of Menopause Symptoms with New Drugs by “Atipharmed”
The pharmaceutical company “Atipharmed,” a subsidiary of the Actover Group, has introduced two new drugs to the national market, which are used for hormone therapy and alleviating post-menopause symptoms and issues.
Production of the first drug approved by FDA for the treatment of severe alopecia areata in Iran
Baricitinib, marketed under the brand name Actonib, is the first FDA-approved medication for the treatment of moderate to severe alopecia areata in adults.
Helping to Treat Neuropathic Pain and Anemia with an Iranian Supplement
In a ceremony attended by specialists in endocrinology, neurology, and nutrition, Nexus, a subsidiary of the Actoverco Pharmaceutical Group, unveiled its new product, “Neurostyle.”
20th Congress of Gynecologists and Obstetricians
Enthusiastic Reception by Doctors and Specialists at the 20th Congress of Gynecologists and Obstetricians
The combined diabetes medicine was produced by Iranian scientists!
Researchers at Actoverco pharmaceutical company, have succeeded in producing a type of oral combination drug for diabetes that can be used to control blood sugar in individuals with type 2 diabetes.
Actoverco launches diabetes drug “Trytis”
Actoverco pharmaceutical Group produce new drug which is named “Trytis” and it will be launched as soon.
“International Labour Day”
International Labour Day is a valuable opportunity to honor and appreciate the selfless efforts and services of the honorable and hardworking workers.
Actoverco host a Futsal tournament!
Futsal tournament for active athletes in the medical and therapeutic fields with the slogan “Together for health” will be held by Actoverco pharmaceutical group in June.